Use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation - Messages from the 2018 EHRA

被引:4
作者
Tomaszuk-Kazberuk, Anna [1 ,2 ]
Koltowski, Lukasz [1 ,3 ]
Balsam, Pawel [1 ,3 ]
Kozinski, Marek [1 ,4 ]
Kaplon-Cieslicka, Agnieszka [1 ,3 ]
Kupczynskal, Karolina [1 ,5 ]
Domienik-Karlowicz, Justyna [1 ,6 ]
Budaj-Fidecka, Anna [1 ,3 ]
Buszman, Piotr [1 ,7 ,8 ]
Wybraniec, Maciej [1 ,9 ]
Burchardt, Pawel [1 ,10 ,11 ]
Michalski, Blazej [1 ,5 ]
Jaguszewski, Milosz J. [1 ,12 ]
机构
[1] Polish Cardiac Soc, Club 30, Krakow, Poland
[2] Med Univ Bialystok, Dept Cardiol, Bialystok, Poland
[3] Med Univ Warsaw, Dept Cardiol 1, Ul Banacha 1a, PL-02097 Warsaw, Poland
[4] Nicolaus Copernicus Univ, Coll Med, Dept Principles Clin Med, Bydgoszcz, Poland
[5] Med Univ Lodz, W Bieganski Hosp, Dept Cardiol, Lodz, Poland
[6] Med Univ Warsaw, Dept Internal Med & Cardiol, Ctr Diag & Treatment Venous Thromboembolism, Warsaw, Poland
[7] Amer Heart Poland, Ctr Cardiovasc Res & Dev, Katowice, Poland
[8] Med Univ Silesia, Clin Dept Cardiol 3, Silesian Ctr Heart Dis, Zabrze, Poland
[9] Med Univ Silesia, Sch Med Katowice, Dept Cardiol 1, Katowice, Poland
[10] Poznan Univ Med Sci, Dept Biol & Lipid Disorders, Poznan, Poland
[11] J Strus Hosp, Dept Cardiol, Poznan, Poland
[12] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland
关键词
PROTHROMBIN COMPLEX CONCENTRATE; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; ASSAYS LABORATORY RECOMMENDATIONS; ASSOCIATION PRACTICAL GUIDE; HEALTH-CARE PROFESSIONALS; DAILY DOSING FREQUENCY; DRUG-DRUG INTERACTION; FACTOR XA INHIBITOR; THROMBOEMBOLIC EVENTS;
D O I
10.5603/CJ.2018.0080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:423 / 440
页数:18
相关论文
共 50 条
  • [1] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Steffel, Jan
    Verhamme, Peter
    Potpara, Tatjana S.
    Albaladejo, Pierre
    Antz, Matthias
    Desteghe, Lien
    Haeusler, Kart Georg
    Oldgren, Jonas
    Reinecke, Holger
    Roldan-Schilling, Vanessa
    Rowell, Nigel
    Sinnaeve, Peter
    Collins, Ronan
    Camm, A. John
    Heidbulchel, Hein
    EUROPEAN HEART JOURNAL, 2018, 39 (16) : 1330 - 1393
  • [2] Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Plitt, Anna
    Ruff, Christian T.
    Giugliano, Robert P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1019 - +
  • [3] Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation
    Fanaroff, Alexander C.
    Ohman, E. Magnus
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 61 - 75
  • [4] Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory
    Blann, A. D.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2014, 71 (04) : 158 - 167
  • [5] Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
    Gelosa, Paolo
    Castiglioni, Laura
    Tenconi, Marco
    Baldessin, Ludovico
    Racagni, Giorgio
    Corsini, Alberto
    Bellosta, Stefano
    PHARMACOLOGICAL RESEARCH, 2018, 135 : 60 - 79
  • [6] 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
    Steffel, Jan
    Collins, Ronan
    Antz, Matthias
    Cornu, Pieter
    Desteghe, Lien
    Haeusler, Karl Georg
    Oldgren, Jonas
    Reinecke, Holger
    Roldan-Schilling, Vanessa
    Rowell, Nigel
    Sinnaeve, Peter
    Vanassche, Thomas
    Potpara, Tatjana
    Camm, A. John
    Heidbuechel, Hein
    Lip, Gregory Y. H.
    Deneke, Thomas
    Dagres, Nikolaos
    Boriani, Giuseppe
    Chao, Tze-Fan
    Choi, Eue-Keun
    Hills, Mellanie True
    Santos, Itamar de Souza
    Lane, Deirdre A.
    Atar, Dan
    Joung, Boyoung
    Cole, Oana Maria
    Field, Mark
    EUROPACE, 2021, 23 (10): : 1612 - 1676
  • [7] Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation
    Hylek, Elaine M.
    Ko, Darae
    Cove, Christina L.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 783 - 788
  • [8] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary
    Steffel, Jan
    Verhamme, Peter
    Potpara, Tatjana S.
    Albaladejo, Pierre
    Antz, Matthias
    Desteghe, Lien
    Haeusler, Karl Georg
    Oldgren, Jonas
    Reinecke, Holger
    Roldan-Schilling, Vanessa
    Rowell, Nigel
    Sinnaeve, Peter
    Collins, Ronan
    Camm, A. John
    Heidbuchel, Hein
    EUROPACE, 2018, 20 (08): : 1231 - 1242
  • [9] Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation
    Saliba, Walid
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (05) : 323 - 335
  • [10] Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal
    Reddy, Sujan T.
    Cossey, T. C.
    Savitz, Sean I.
    Grotta, James C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (09)